| Global Med Technologies, Inc. | |||
| Ticker: | GLOB | 12600 West Colfax, Suite A-500 | |
| Exchange: | NASDAQ-Small Cap Market | Lakewood, CO 80215 | |
| Industry: | Service (SIC Code 8741) | (303) 238-2000 | |
| Type of Shares: | Common Shares | Filing Date: | 9/11/96 | |
| U.S. Shares: | 2,674,000 | Offer Date: | 2/11/97 | |
| Non-U.S. Shares: | 0 | Filing Range: | $7.00 - $9.00 | |
| Primary Shares: | 2,674,000 | Offer Price: | $3.50 | |
| Secondary Shares: | 0 | Gross Spread: | $0.35 | |
| Offering Amount: | $21,392,000 | Selling: | $0.21 | |
| Expenses: | $240,000 | Reallowance: | $0.10 | |
| Shares Out After: | 7,111,269 |
| Manager | Tier | Phone |
| RAF Financial Corporation | Lead Manager | (800) 777-1717 |
| First of Michigan Corporation | Co-manager | (313) 259-2600 |
| Issuer's Law Firm: | Brenman, Key & Bromberg |
| Bank's Law Firm: | Smith, McCullough & Ferguson, P.C. |
Dollar amounts in U.S. millions except for per share data | |||||
| Full Year Audited Income | Latest Unaudited Income | Prior Unaudited Income | Balance Sheet | ||
| 12/31/95 | 6/30/96 | 6/30/95 | 6/30/96 | ||
| Revenue: | $6.67 | $5.98 | $3.26 | Assets: | $4.96 |
| Net Income: | -$2.69 | -$0.40 | -$0.02 | Curr Assets: | |
| EPS: | -$0.70 | -$0.01 | -$0.01 | Liabilities: | $6.12 |
| Prior EPS: | Curr Liabilities: | ||||
| Cash Flow/Oper: | Equity: | -$1.16 | |||
| Cash Flow/Fin: | Cash: | ||||
| Cash Flow/Inv: | |||||
| Business Description |
| Global Med Technologies, Inc. provides information management software products and services to the healthcare industry and provides substance abuse testing program service to companies, including certain Fortune 100 companies. The company consists of two divisions, DataMed International and Wyndgate Technologies, both of which operate under their respective trade names. Wyndgate develops, markets, licenses and supports software for the healthcare industry. DataMed manages and markets a variety of services that are designed to assist companies with administering substance abuse testing programs. Founded in 1984, Wyndgate initially developed a Student Information System, an integrated software package for colleges and universities to track student information. Wyndgate currently has five university contracts for SIS still in effect. Pursuant to an agreement with eight California blood centers, Wyndgate began development of a blood tracking system to assist community blood centers, hospitals, plasma centers and outpatient clinics in the U.S. |
| Business Plan |
| The following are key elements of the company's strategy; however, there can be no assurance that the company will be successful in its strategy. 1) Expand sales & marketing efforts; 2) develop new healthcare management software products and services; 3) expand international markets; 4) develop strategic relationships; 5) maintain technology advantage. |
| Use of Proceeds |
| The proceeds from the proposed offering will be used to pay research and development costs, sales and marketing costs and existing debt, and for general working capital. |
| # of Units: | 1,337,000 | |||
| Unit Ticker: | GLOBU | Unit Price: | $7.00 | |
| Warrant Ticker: | GLOBW | Warrant Price: | ||
| Warrant Exercise Date: | Warrant Exercise Price: | |||
| Warrant Expiration Date: | ||||
| Warrant Detachable: | Yes | Warrant Detach Date: | ||
| Warrant Callable: | No |
| Unit Composition: 2 Common Shares + 1 Warrant |
| Warrant Entitlement: 1 Common Share |